Approximately 2,856 bottles of Venlafaxine (50 mg), a prescription antidepressant, have been recalled because some bottles may contain incorrect tablets of a lower strength (37.5 mg). This error means patients could unknowingly receive an incorrect dose of their medication, which may lead to a recurrence of symptoms or withdrawal effects. The affected products were manufactured for Northstar Rx LLC and distributed in bottles of 100 tablets. Consumers should immediately check their medication bottles and contact their healthcare provider to ensure they are taking the correct dosage.
Taking a lower dose of Venlafaxine than prescribed can result in the return of depression or anxiety symptoms and may cause physical withdrawal symptoms. There is a risk of therapeutic failure if a patient unknowingly consumes the 37.5 mg tablets instead of the prescribed 50 mg tablets.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.